IFNG and non-small cell lung carcinoma: Figure 3F clearly indicates that Treg significantly decreased IFNγ-production by activated CD4+ T-cells in a dose-dependent manner in NSCLC patients. Isolated CD4+ Treg (CD127−/lowCD25+CD4+) from HDs showed an equivalent suppressive capacity (Fig. 3F, inset).